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Placental miR-340 mediates vulnerability to activity
based anorexia in mice
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Anorexia nervosa (AN) is a devastating eating disorder characterized by self-starvation that
mainly affects women. Its etiology is unknown, which impedes successful treatment options
leading to a limited chance of full recovery. Here, we show that gestation is a vulnerable
window that can inﬂuence the predisposition to AN. By screening placental microRNA
expression of naive and prenatally stressed (PNS) fetuses and assessing vulnerability to
activity-based anorexia (ABA), we identify miR-340 as a sexually dimorphic regulator
involved in prenatal programming of ABA. PNS caused gene-body hypermethylation of pla-
cental miR-340, which is associated with reduced miR-340 expression and increased protein
levels of several target transcripts, GR, Cry2 and H3F3b. MiR-340 is linked to the expression
of several nutrient transporters both in mice and human placentas. Using placenta-speciﬁc
lentiviral transgenes and embryo transfer, we demonstrate the key role miR-340 plays in the
mechanism involved in early life programming of ABA.
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Eating disorders (ED) are destructive mental disorders thatdramatically decrease quality of life and have life-threatening consequences. They are ten times more com-
mon in women than in men and represent one of the most
common psychiatric disorders, affecting up to 4.5% of women at
some point in their lives1. Anorexia nervosa (AN), the most
severe ED, accounts for the highest mortality rate of all mental
illnesses (about 10%)2. Despite being so immensely destructive to
health and affecting such a signiﬁcant number of young women,
the understanding of AN remains poor due to its multi-factorial
and complex origins. As a consequence, treatment is sparse,
unspeciﬁc and unlikely to lead to full recovery3.
Due to the signiﬁcantly greater prevalence of AN in women,
most of the clinical literature and preclinical models have aimed
at providing a rationale for speciﬁc factors precipitating AN
disproportionately in females at the time of puberty4. Suscept-
ibility to EDs is often associated with early life stress or trauma5,6.
However, it is important to make a distinction between the dif-
ferent types of “early life trauma” and how they may affect sub-
sequent predisposition to disease. Trauma during childhood may
serve as a trigger for an existing predisposition, while gestational
or even pre-gestational trauma may be more involved in pro-
gramming the predisposition or protecting from it, depending on
the severity, timing, and extent of the insult7. As such, increased
risk of bulimia nervosa and mixed eating disorders was reported
among girls who were exposed to either prenatal stress (PNS) or
early postnatal life stress. In contrast, this was not true for AN8.
Yet, early postnatal and childhood trauma are both frequently
referred to as “early life”, but they are in fact taking place at
different developmental windows, exerting potentially very dif-
ferent effects on the susceptibility for the different eating dis-
orders in the offspring.
In any case, stress alone does not necessarily prompt EDs but
rather a combination of an innate predisposition pooled with the
additive effect of early life trauma is more likely to lead to dis-
ease5,9. This concept coincides with the developmental origin of
health and disease hypothesis, and has received compelling epi-
demiological support from animal studies. Early life stress, par-
ticularly in the form of intrauterine maternal emotional stress or
nutrition-related (high fat diet/deprivation), may ultimately pre-
dispose male and female offspring to different diseases10–12. The
fetal perception of the intrauterine environment is mediated by
the placenta, a feto-maternal organ that connects the developing
fetus to the uterine wall to allow nutrient uptake, waste elim-
ination, and gas exchange via the mother’s blood supply.
Although the placenta has long been considered a “sexless” organ,
in fact given its predominantly fetal origin, it carries the same
genetic information as the fetus and is therefore differentially
sensitive to environmental stimuli13 and fetal hormones14. The
placenta of one sex may also possess a greater ability to respond
and buffer against selective environmental insults15, as is the case
for the sex-speciﬁc placental contribution to nutritional pro-
gramming in the offspring16. It is broadly recognized that com-
promised placental function can have both short- and long-
lasting consequences for the developing fetus, e.g., with maternal
hypoxia, pre-eclampsia, or placental insufﬁciency17, which are
closely related to a speciﬁc stage of development and fetal sex.
Finally, distinct sex-dependent structural and functional placental
factors have been repeatedly reported in normal pregnancies
(reviewed in ref. 15). This further suggests that the physiological
and molecular basis for the sex-speciﬁc developmental trajectory
toward susceptibility to disease may originate in utero, through
placental disparities between the sexes despite exposure to a
similar maternal environment.
Recently, microRNAs (miRs) have received major attention in
the context of placenta-associated abnormalities18. Speciﬁc
placental miRs were found to be associated with several preg-
nancy disorders and therefore are strong candidates for the
mediation of gestational programming19. In the present study, we
explored this possibility by comparing placental differences in
miR expression between opposite sex siblings of undisturbed and
PNS pregnancies in parallel to adolescent susceptibility to
activity-based anorexia (ABA). The ABA model successfully
mimics the choice of exercise above eating, relying on limited
food intake while allowing unlimited access to running wheels
(RW)20. While ﬁrst modeled in rats, the ABA model has also been
widely examined in mice21 with varying criteria22. It is char-
acterized by dramatic weight loss as a consequence of decreased
food intake21, hyperactivity and circadian disruption in the
running pattern23.
To test our hypothesis that susceptibility to AN may originate
in utero, we examined placental miR expression in control and
PNS mice and exposed a parallel cohort to the ABA protocol
during adolescence. We demonstrate that susceptibility to ABA is
associated with endogenous levels of placental miR-340 and
overexpression dramatically increased the susceptibility to ABA.
We propose that programming of ABA vulnerability originates in
utero, and renders speciﬁcally female offspring vulnerable to
metabolic challenges during adolescence.
Results
ABA affects mainly adolescent females and is abolished by
PNS. To examine the vulnerability of female mice to ABA, we
exposed them to a modiﬁed version of the ABA protocol24 when
they reached adolescence. We allowed the animals to habituate to
voluntary wheel running for 1 week with free access to food,
followed by 5 days of free access to wheels combined with gradual
food restriction (FR) in the form of 3–4 h of food access a day,
during the dark cycle (Fig. 1a). An undisturbed control group
with no wheels and free access to food as well as a further FR
group with no access to wheels was added to control for the
impact of FR on body weight (BW). The results revealed similar
BW in all control female groups with free access to food. FR alone
did not induce perdurable weight loss despite the reduction in
food consumption, suggesting that the number of calories con-
sumed was enough to maintain their BW if the necessary
adjustments were made (such as reduction in general activity). In
contrast, when exposed to the ABA protocol (FR+ RW), the
animals split into two sub-groups, denominated either “Resistant”
(Res) or “Anorexic” (ABA). Overall, 40% of the control females
developed ABA and 60% were resistant (Fig. 1b). Classiﬁcation of
the animals into each category was performed retrospectively by
cluster analysis, based on the following parameters during the FR
phase of the protocol: (1) BW loss; (2) Food intake in kcal; (3)
Food intake recovery (% from the ﬁrst FR day); (4) Circadian
disruption (running distance in km during the light phase); (5)
Total distance ran with FR (total activity) and (6) Time until
collapse (in days). ABA females displayed dramatic weight loss
compared to all other groups (Fig. 1c). Weight loss resulted from
a gradual reduction in voluntary food intake (Fig. 1d). The FR
group and Res females adapted and increased their kcal intake
during the FR period, but ABA females did not (Fig. 1d). While
Res females showed an intact circadian running pattern (Fig. 1e),
ABA females showed disrupted running with high activity levels
during the light phase (Fig. 1f) and running up to 12 km/day
during the FR phase (Fig. 1g). In the long term (about 6 weeks
after the end of the intervention), all females exposed to food
restriction during adolescence weighed more than undisturbed
controls, but did not differ according to predisposition to ABA
(Fig. 1h). In order to better characterize each female mouse in this
experiment, we assigned them an “ABA score” composed by the
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sum of the Z scores of the ABA parameters. Accordingly, ABA
females (as revealed by the previous cluster analysis) scored sig-
niﬁcantly higher on this new scale than Res females (Fig. 1i).
Finally, we examined gene expression in the hypothalamus,
focusing on genes that have been speciﬁcally linked to anorexia in
women and in various animal models as potential candidates.
Hypothalamic dysregulation in anorexia has been reported for the
melanocortin, the neurotrophic and the serotonin systems and
the HPA axis. We chose representative genes of these systems that
repeatedly emerged as potential mediators of the anorexic phe-
notype: Agouti-related peptide (AgRP)25, Melanocortin receptor
4 (Mc4R)26, Serotonin receptor (Htr)1a27, Bdnf28, Arginine
vasopressin (Avp)29 and Hypocretin/Orexin (Hcrt)30. We found
that, as expected, AgRP, Htr1a, Avp and Hcrt were dysregulated in
recovered ABA animals (Fig. 1j).
In order to test the potential mechanistic link between early life
stress and later predisposition to ABA, we performed PNS on a
further set of females starting 1 day after the detection of the
copulation plug and until GD.16.5, that induced the expected
stress-related responses in the mother and the fetuses (Supple-
mentary Fig. 1A). The resulting offspring, including males, were
then exposed to the ABA protocol upon reaching adolescence
(Fig. 1k). We next calculated the Z scores for each ABA
parameter according to their strength of prediction as determined
by a two-step cluster analysis in the original female group (Fig. 1l,
raw data in Supplementary Fig. 2). We found that 30-day-old
adolescent males and PNS offspring of both sexes scored similarly
to Res females in intake recovery (Fig. 1m), days until collapse
(Fig. 1n), BW change (Fig. 1o), circadian disruption (Fig. 1p),
food intake (Fig. 1q), and total activity with FR (Fig. 1r). Thus, all
males and PNS females were largely resistant to ABA, scoring
similarly to Res control females in the ABA score (Fig. 1s). When
examining basal metabolic parameters in this group, the PNS
females appear to be programmed to become overweight, rather
than underweight, and this may be at least one of the reasons
underlying their resistance to ABA (Supplementary Fig. 1B).
PNS placentas show downregulation of miR-340 by gene-body
DNA methylation. To elucidate the early origins of vulnerability/
resistance to ABA, we next focused on gestational aspects and
placental adaptations in control vs. PNS male and female off-
spring. BW gain in dams subjected to stress when pregnant (PNS
dams) was signiﬁcantly lower than in controls, despite similar
food intake (Fig. 2a, b) and they also showed increased corti-
costerone levels (Fig. 2c). PNS did not affect fetal weight, but did
reduce placental weight in female offspring only, suggesting an
increase in placental efﬁciency in this group (Fig. 2d−f).
Accordingly, placental 11βhsd2, the enzyme that converts active
corticosterone into inactive cortisone, was decreased and fetal
corticosterone levels were increased exclusively in female PNS
fetuses (Fig. 2g, h). This suggests that females were exposed to
higher levels of endocrine stress signals compared to their male
siblings, an effect reported previously31.
To gain better insight into the mechanisms that mediate the
differences between controls and PNS, we next compared the
placental miRs expression proﬁle using miR arrays. We identiﬁed
several miRs differentially expressed in PNS placentas with miR-
340 being most severely affected by the manipulation (Fig. 2i and
Supplementary data 1). We then validated the array ﬁndings by
qPCR and detected a clear sexually dimorphic expression pattern,
since miR-340 was expressed in very low levels in control and
PNS male placentas (Fig. 2j). Importantly, expression of miR-340,
as shown by in situ hybridization, appears to be restricted to the
junctional zone of the placenta in particular on the labyrinth side,
a major site of feto-maternal exchange and hormone production
respectively (Fig. 2k).
To elucidate the regulating mechanism of miR-340 by PNS, we
performed a bioinformatic analysis on the Rnf130 gene, which
hosts miR-340 in its second intron. Like miR-340, Rnf130 was
downregulated by PNS (Supplementary Fig. 3A). Intronic miRs
are frequently found in a sense orientation and thus are
frequently transcribed together with their host gene32. The
analysis revealed that Rnf130 has a CpG island about 800 bp long
around its promoter region and the ﬁrst exon (Fig. 2l).
Furthermore, miR-340 was previously suggested to be regulated
by DNA methylation in different types of cancer33. To examine
this possibility, we used the DNA methyltransferase inhibitor 5-
aza in an in vitro assay and showed that increasing concentrations
of the inhibitor led to increasingly higher levels of miR-340,
implying DNA methylation in its regulation (Fig. 2m). We next
examined the methylation levels in the CpG Island of the Rnf130
promoter and on the miR-340 sequence through bisulﬁte
conversion and pyrosequencing in control and PNS female
placentas. While DNA methylation at promoters is widely
accepted to be associated with transcriptional repression, recent
studies suggested that gene body methylation also plays a critical
role in gene regulation34. Interestingly, the CpG Island in the
Rnf130 promoter region displayed very low levels of methylation,
both in female control and PNS placentas (Supplementary
Fig. 3B). In contrast, the two CpGs located on the sequence of
miR-340 revealed high methylation in both groups, with CpG2
signiﬁcantly more methylated in PNS than in control female
placentas (Fig. 2n), which also show global hypermethylation
compared both to control females and males (Fig. 2o). Taken
together, these ﬁndings suggest that placental miR-340 is a
sexually dimorphic miRNA robustly affected by PNS and
regulated through gene body DNA methylation.
MiR-340 targets Nr3c1/GR, Cry2, and H3f3b in the placenta.
In order to explore the mechanism through which placental miR-
340 exerts its effects on ABA predisposition, we next performed
bioinformatic predictions on potential targets focusing on genes
involved in placental functioning and structure. The conservation
of the miR-340 seed matches on the 3′UTR of these targets are
shown in Supplementary Fig. 4. Based on those predictions, we
performed a Taqman custom gene expression array comparing
placentas of control and PNS females. Among the potential tar-
gets, Sirt7, Nr3c1 (which encodes the GR), Hdac9, Histone 3
mammalian isoform, family 3b (H3f3b) and Ythdf3 were upre-
gulated in placentas of PNS females (Supplementary Table 1). We
expanded the analysis using RT-PCR, adding additional samples
and performing correlations between the expression of miR-340
and the putative targets (Fig. 3a−f). GR (Fig. 3b), Hdac9 (Fig. 3c),
Cry2 (Fig. 3d), and H3f3b (Fig. 3e) showed a signiﬁcant inverse
correlation with the expression of miR-340 in these samples,
while Sirt7 (Fig. 3a) and Ythdf3 did not (Fig. 3f). When examining
the PNS group alone, the strongest correlations were evident for
GR/GR, Cry2/CRY2, and H3f3b/H3F3b (Supplementary Fig. 5a),
which also showed increased placental protein levels (Fig. 3g−i).
In contrast, Hdac9/HDAC9 did not show a similar effect (Sup-
plementary Fig. 5b). To explore the link between the miR-340 and
the relevant targets further, we next infected BeWo placental cells
with a lentivirus designed to knockdown (KD) miR-340 and thus
mimic the effects of PNS. As expected, the KD virus signiﬁcantly
reduced the expression of miR-340 in the cells (Fig. 3j). In
addition, while mRNA levels did not change signiﬁcantly in any
of the putative targets (Fig. 3k), we found an increase in protein
levels of GR, CRY2, and H3F3b (Fig. 3l), but again not in HDAC9
(Supplementary Fig. 5B).
Given the variability within the control female group in
vulnerability to ABA, we next focused on this group in an
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additional experiment where we analyzed the relative expression
of miR-340 in 28 female samples from an additional six control
pregnant females. Nine out of the 28 placentas (32%) showed
miR-340 levels 25% above the average (Fig. 3m), which resembles
the number of ABA-prone females in our ﬁrst group (40%).
Remarkably, the levels of miR-340 were affected by the sex of the
adjacent fetus. Females located between two males showed the
lowest levels of miR-340 (Fig. 3n), suggesting prenatal androgen
exposure may be linked to miR-340 expression levels and the
subsequent resistance to ABA. Furthermore, we found an inverse
correlation with the expression of miR-340 for GR, Cry2, and
H3f3b in this group (Fig. 3o−q). Finally, we examined the
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expression of the AN candidate genes in the hypothalamus of the
fetuses according to placental miR-340 levels. We found that
AgRP and Hcrt were highly expressed in control fetuses with high
levels of miR-340 compared to fetuses with low levels of miR-340.
In contrast, Htr1a and Bdnf were decreased (Fig. 3r).
MiR-340 inversely correlates with placental amino acid trans-
porters. To gain insight into the potential effects of miR-340
levels on placental function and the uterinal environment that the
fetuses were exposed to, we performed RNAseq in placentas with
high and low endogenous miR-340 levels (Fig. 3m). Sleuth gene
expression analysis revealed 881 upregulated and 779 down-
regulated genes in the high miR-340 group. Of these, we chose to
focus on the solute carrier (SLC) group of membrane transport
proteins, as well as on cholesterol transporters and the insulin-
like growth factor (IGF) family given their crucial involvement in
placental structure and function35. The two groups’ proﬁles
appear remarkably different in their capacity to allocate nutrients,
as reﬂected by the different global expression in selected nutrient
transporters (Fig. 4a). In particular, the levels of miR-340 inver-
sely correlate with the expression of the amino acid transporters
Slc7a5c, Slc7a11, and Slc38a1; the main lactate transporter Slc16a3
and Igf2 and Igf2bp1 in mice (Fig. 4b). The Igf2 and the Igf family
are heavily involved in nutrient transport and can further regulate
thickness of the interhemel membrane connecting the maternal
and fetal circulation36. Therefore, we examined the thickness of
the junction in the two groups and found a thicker junctional area
in the high miR-340 group, which was in accordance with
reduced Igf2 levels36 (Fig. 4c). When we explored the potential
link between miR-340 levels and these transporters and growth
factor, we found a potential pathway through the targets Nr3c1,
Cry2, and H3f3b (Fig. 4d, based on STRING database https://
string-db.org37). These ﬁndings suggest that the particular loca-
tion of miR-340 in the junction may be linked to the regulation of
nutrient transport to the fetuses, both by reducing fetal access to
nutrients and amino acids and potentially through structural
changes via Igf2. To examine the translational potential of our
ﬁndings, we collected central, medial, and lateral human placental
samples from healthy, full-term male and female pregnancies (see
Supplementary Table 3 for the mothers’ demographics and
clinical characteristics). Analysis of the expression of miR-340
showed similar levels among boys and in the medial and lateral
areas, but girls presented dramatically higher levels in the central
area, which is closest to the umbilical cord (Fig. 4e). Similarly to
mice, human female placentas showed a higher variability in the
expression of miR-340 and when correlated with the expression
of the relevant transporters identiﬁed in mice, we found an
inverse correlation between miR-340 and SLC7A5, SLC7A11,
SLC38A1, SLC16A3, IGF2, and IGF2BP1 (Fig. 4f, further trans-
porters examined are presented in Supplementary Table 3). Thus,
the results suggest that miR-340 may be involved in mediating the
fetal acquisition of selective nutrients, thus affecting develop-
mental programming of the offspring, both in humans and in
mice.
MiR-340 overexpression increases susceptibility to ABA. With
the aim of exploring whether high levels of placental miR-340 are
directly related to increased vulnerability to ABA, we next gen-
erated placenta-speciﬁc transgenes38,39. Blastocysts were then
infected with lentiviruses designed to overexpress (OE) miR-340
or with a control virus (CV) and were then transferred into
pseudo-pregnant females for further development (Fig. 5a). As
expected, infection of the blastocysts’ trophoblast cells with len-
tiviruses led to placenta-speciﬁc infection (Fig. 5b) predominantly
in the junctional area of the placenta (Supplementary Fig. 6).
Validation of miR-340 expression in placentas infected with the
miR-340 OE virus conﬁrmed a threefold increase in miR-340
levels in both sexes. A similar increase was found in infected
BeWo cells (Fig. 5c). Examination of fetal hypothalamic expres-
sion of AN candidate genes revealed a similar proﬁle to wild-type
females with high endogenous expression of placental miR-340,
including upregulation of AgRP and downregulation of Htr1a
(Fig. 5c and Fig. 3r).
We next explored the mRNA expression and protein levels of
the targets both in the transgene placentas and in infected BeWo
cells respectively. As expected, miR-340 OE generally inversely
correlated with mRNA and protein of the targets in placental
samples (Fig. 5d, f, h) and in BeWo cells (Fig. 5e, g, i). In a
separate set of pregnancies, the transferred embryos were allowed
to reach term. They remained untouched until 30 days old, when
they underwent the ABA protocol (Fig. 6a). To determine
susceptibility to ABA, we next calculated the Z scores of the ABA
parameters according to the prediction strength of the original
experiment (Fig. 1k). All raw data are presented in Supplemen-
tary Fig. 7. Accordingly, we found that the pattern of food intake
recovery during FR was inefﬁcient in miR-340 OE animals
Fig. 1 Adolescent females show high susceptibility to activity-based anorexia (ABA), which is absent in males and is abolished by prenatal stress (PNS) in
females. a ABA protocol experimental design. b Hierarchical cluster analysis split the females into ABA-prone and resistant to ABA. c, d The ABA protocol
induced a dramatic decrease in body weight (BW) (repeated measures ANOVA F(27,60)= 4.17, p= 0.000 for time × treatment interaction) and food
intake (F(33,54)= 3.71, p= 0.000 for time × treatment interaction) in ABA females compared to all other groups (N= 6 for undisturbed, N= 6 for FR, N= 8
for ABA and N= 12 for resistant). e, f Running pattern was normal in resistant females (e) and disrupted in the ABA group, which displayed high activity in
the light phase (f). g Total running distance was signiﬁcantly increased during food restriction (FR) in the ABA group (Fint(1,14)= 7.33, p= 0.017). h Long-
term BW differed between the groups (repeated measures ANOVA Fint(15,100)= 6.67, p < 0.0001). All FR females weighed signiﬁcantly more than
undisturbed females. *p < 0.05 ABA vs. Resistant, #p < 0.05 ABA vs. FR and (black club) p < 0.05 ABA vs. undisturbed based on Tukey’s multiple
comparisons test. Data are presented as mean and s.e.m. i ABA animals scored signiﬁcantly higher in the global ABA score compared to resistant females
(Student’s t test t(18)= 10.49, p < 0.0001), which is composed of the sum of the Z scores of the six ABA parameters. Data presented in min. to max with
median. j Hypothalamic gene expression of AN candidate genes differed between resistant and ABA females (MANOVA F(6,5)= 24.60, p= 0.001). k To
test the sex speciﬁcity and the contribution of PNS to ABA predisposition, we tested PNS offspring of both sexes together with control males on the ABA
protocol using one-way ANOVA for each parameter with Tukey’s multiple comparisons test. l ABA individual parameters for the males and PNS animals
were calculated in Z scores according to each parameter’s strength of prediction. m−r Control males and PNS males and females scored similarly low in
food intake recovery (F(4,49)= 7.26, p < 0.0001) (m), days until collapse (F(4,49)= 82.89, p < 0.001) (n), BW change (F(4,49)= 9.81, p < 0.0001) (o),
circadian disruption (light phase activity)(F(4,49)= 13.06, p < 0.0001) (p), food intake (F(4,49)= 7.06, p < 0.0001) (q) and total activity (F(4,49)= 8.34, p <
0.001) (r) compared to resistant control (C-Res) females. s While control females split into resistant and ABA-prone subgroups, PNS females and all
males were largely resistant to ABA (F(4,49)= 32.30, p < 0.0001). RW running wheel, CTRL control. Data presented as min. to max with median
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(Fig. 6b). MiR-340 OE transgenes collapsed more frequently
toward the end of the food restriction period (Fig. 6c), displayed
higher BW change (Fig. 6d) and showed circadian disruption as
reﬂected by the distance run (km) in the light phase (Fig. 6e)
compared to transgene controls. While food intake during FR was
not signiﬁcantly affected (Fig. 6f), miR-340 OE induced
hyperactivity in both males and females (Fig. 6g). Taken together,
these parameters exposed the signiﬁcantly higher susceptibility to
ABA in miR-340 OE transgenes of both sexes, as reﬂected by the
higher ABA score compared both to wild type (WT) and CV
controls (Fig. 6h). Finally, hypothalamic assessment of AN
candidate genes in these groups revealed long-lasting down-
regulation of AgRP and upregulation of Htr1a, resembling the
expression patterns found in the original control ABA group
(Fig. 6i and Fig. 1j) and further conﬁrming the central role played
by the hypothalamic melanocortin and serotonin systems in
anorexia. Altogether, these ﬁndings translated into higher
percentages of animals being prone to ABA as a result of miR-
340 OE (Fig. 6j).
Taken together, we propose that placental miR-340, through
the regulation of genes known to be involved in placental
structure and function, such as GR, Cry2 and H3f3b and
downstream nutrient transporters, can change the fetal environ-
ment and hypothalamus to induce later life susceptibility or
resistance to ABA (Fig. 7).
Discussion
In the current set of studies, we have identiﬁed, for the ﬁrst time,
a potential mechanism of ABA gestational programming. It
appears that early life variables that affect placental gene
expression may play a crucial role in this predisposition. These
ﬁndings are supported by the genetic epidemiology of AN, which
indicates strong evidence for familial contribution but does not
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always provide convincing evidence of hereditability according to
population-based homozygous twin studies40,41. When it comes
to gestational programming, the placenta plays a central part in
shaping the fetal environment42. Placentas exhibit pronounced
sexual dimorphism in response to variation in the maternal
milieu both in humans43 and mice31,44, which appears to be the
case for miR-340 in the junctional zone of the mouse placenta.
This zone contains zygote-derived cytotrophoblasts, which have
direct access to the maternal blood ﬂow45. Two types of cyto-
trophoblasts exist in this zone at GD17.5 in mice, spongio-
trophoblasts and trophoblast glycogen cells, both of which
synthesize protein hormones such as IGF2, a key growth and
nutrient supply gene46. The human and mouse placentas share a
similar function, but are structurally quite different. The corre-
sponding region to the murine junctional zone in humans is the
basal plate, which differently from mice presents multi-layered
cytotrophoblastic columns with a morphological gradient of cells.
Despite this difference, in both species this region does not
contain any fetal blood, but is traversed by maternal blood
channels lined by zygote-derived trophoblast cells, through which
maternal blood ﬂows into and out of the fetal placenta/
labyrinth45.
The placental responses to stress include adaptations at mul-
tiple epigenetic levels, which affect molecular processes on a
global scale. Abnormal DNA methylation is one of these pro-
cesses47, that in turn shapes placental morphology with far-
reaching implications including impairments in placental devel-
opment and nutrient supply. Maternal stress during pregnancy
broadly inﬂuences the placenta, inducing the very well docu-
mented and varied negative effects in the offspring such as
anxiety, depression, cognition, memory48,49, and metabolism50.
When PNS is limited to the last week of gestation, unlike our
protocol, susceptibility to ABA appears to increase in a subset of
rats30. A similar ﬁnding was recently reported for binge eating
disorder using a different stress model but the same window of
intervention51. Thus, ABA resistance resulting from chronic PNS
may represent a beneﬁcial side effect of an otherwise negative
overall outcome.
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Fig. 4 MiR-340 is associated with differential expression of nutrient transporters both in mouse and human female placenta. a Heat-map comparing
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the high miR-340 group (t(6)= 3.07, p= 0.022). d STRING pathway analysis linking the miR-340 targets Nr3c1, Cry2, and H3f3b with selected nutrient
transporters (https://string-db.org). e Expression of miR-340 in the human placenta in central, medial, and lateral areas. Girls present higher levels in the
central area compared to boys (two-way ANOVA F(1,104)= 14.78, p < 0.0001). Data are presented as mean and s.e.m. f The expression of SLC7A5, SLC7A11,
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Overexpression of GR, as seen in our placental PNS samples,
induced multiple neuroendocrine changes that have been shown
to result in a blunted response to restraint stress and to endotoxic
shock in a different animal model52. Accordingly, high maternal
cortisol in utero and/or inhibition of 11βHSD2 are associated with
programmed outcomes in childhood including higher blood
pressure, behavioral disorders, and altered brain structure53.
Given the remarkable resistance of males to ABA, a potential
mechanism of ABA prevention in females by PNS may be related
to its well-known masculinizing effects. PNS increases anogenital
distance, which is a sexually dimorphic biomarker of prenatal
androgen exposure in many species54. We noticed that females
were undistinguishable from males in the PNS group at birth due
to larger than usual anogenital distance. This effect resembles
prenatal testosterone exposure, which was shown to masculinize
the food intake pattern of female offspring55. Moreover, dis-
organized eating in girls may be improved by prenatal androgen
exposure, as shown in a twin study in which female pairs had
signiﬁcantly higher disordered-eating scores than girls with male
twins56. This “prenatal androgen exposure hypothesis” has been
more frequently linked to autism spectrum disorders57, but could
also be involved in determining the level of predisposition to ABA
in females. This is particularly likely given the well-documented
effects of uterine position on the fetuses: females developing
between two males are more likely to show masculinized beha-
vioral, anatomical physiological traits due to the transfer of tes-
tosterone from the adjacent fetuses58. This could be a potential
source of the great variability adolescent WT females show in
their response to ABA. Thus, females surrounded by other female
fetuses may be more vulnerable to ABA as suggested by human
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twin studies56,59. While the sex-speciﬁc physiological mechanism
through which placental miR-340 methylation and expression is
determined under both stressful and normal conditions remains
unclear, hormonal alterations in utero may represent a potential
candidate as suggested by Rnf130 regulation by LH/hCG in
Leydig cells in rats60. Finally, the fact that ABA and AN are
typically triggered during adolescence may further suggest that
the prenatal hormonal effects on female offspring may form a
platform for a later triggering or protective effect of gonadal
steroids on this phenotype.
The modulation of the targets identiﬁed here, and potentially
dozens of further targets by miR-340, likely affect nutrient
transporters and growth factors, which may have in turn a pivotal
inﬂuence on fetal development and programming. The ability of a
single miR molecule to affect the functional levels of multiple
proteins/pathways supports therefore their possible involvement
in complex disorders, such as EDs, which are suggested to be
polygenic by nature and inﬂuenced by gene × environment
interactions61. Similarly to miRs, transcription factors like GR62
are highly involved in the regulation of gene expression. GR is
widely expressed both in the labyrinth and the junctional zone of
the murine placenta63. It is involved in the expression and
alteration of a great number of placental genes including the
regulation of trans-placental glucose transfer, through
modulation of the glucose64 and amino transporters. It is there-
fore a crucial factor for sustaining fetal life and securing its
normal development65 affecting the newborns’ neurobehavior66.
GR interacts with Cry2, a key component of the circadian core
oscillator complex that regulates the circadian clock and has been
detected both in the labyrinth and the junctional zone in rats67.
The clock genes are widely involved in the regulation of placental
function, suggesting that normal circadian variations may be
involved in a healthy placental phenotype67. Finally, H3f3b, one
of the replication-independent variants of the Histone 3 mam-
malian isoform, is enriched in coding regions and at speciﬁc
chromatin landmarks in mouse somatic and embryonic cells68.
While its role in placental structure and functioning is largely
unknown, it is suggested to affect chromatin architecture chan-
ging the regulation of epigenetic mechanisms during develop-
ment69. Given their function, it is not surprising that the miR-340
targets may affect the transfer of nutrients to the fetus by reg-
ulating selective transporters. In particular, less transfer of amino
acids to the fetus, as reﬂected by lower expression of three key
transporters, and Igf2, which can affect the thickness of the
junction hindering the transfer of nutrients70.
Overall, we have identiﬁed a placental mechanism through
which miR-340 mediates vulnerability to ABA, likely through
inﬂuencing placental function. MiR-340 presents clear sexual
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dimorphism and is downregulated by PNS inducing a “protec-
tive” effect against ABA. Placenta-speciﬁc OE of miR-340 in
transgene mice exposed its role in the regulation of placental
functioning through GR/Cry2//H3f3b and its involvement in
gestational programming of ABA, potentially inﬂuencing fetal
brain development. Our ﬁndings directly link, for the ﬁrst time,
the variability in the expression of a placental miR with fetal
programming and later vulnerability to AN and provide impor-
tant insights into the ontogeny of this poorly understood ED.
Methods
Animal care. ICR/CD1 mice (Harlan Sprague Dawley Inc., Indianapolis, IN) were
maintained in a pathogen-free temperature-controlled (22 ± 1 °C) mouse facility on
a reverse 12 h light−dark cycle at the Weizmann Institute of Science, according to
institutional guidelines. Food (Teklad Global, Harlan Sprague Dawley Inc.,
Indianapolis, IN) and water were given ad libitum (apart from during FR). All
experimental protocols were approved by the Institutional Animal Care and Use
Committee of the Weizmann Institute of Science.
Breeding. Female ICR mice were mated at 11−13 weeks of age. Two or three
females were housed with one male (minimum age 12 weeks) at the beginning of
the dark period and were examined for the presence of a vaginal copulation plug at
the end of the dark period. Presence of a copulation plug denoted day 0.5 of
gestation. After breeding, the females were individually housed.
Experimental groups. Females with plugs were randomly assigned to the control
or PNS treatment. From day 18.5 of gestation, females were checked twice a day for
the presence of a litter (0900−1000 hours, 1700−1800 hours). Newborn litters
found by 1800 hours were designated as born on that day—postpartum day 0 (PPD
0). On PPD 1, pups were counted and litters were culled to ten pups (with sex
distribution kept as equal as possible in each litter). Litters with less than seven
pups were excluded.
PNS protocol. From gestation day (GD) 1.5 until GD16.5, pregnant females were
exposed to a chronic variable mild stress protocol, including two short manip-
ulations during the dark phase and a further overnight (ON) manipulation during
the light phase. The chosen stressors did not induce pain and did not directly
inﬂuence maternal food intake or weight gain and were repeated on a weekly basis.
The short stressors included multiple cage changes, cage tilt, white noise, water in
cage or no bedding for two periods of 2 h, immobilization in a tube or elevated
platform for 30 min and swim stress in warm water for 15 min. Overnight
manipulations included illumination, saturated bedding (with water), novel object
(marbles), and overcrowding.
Activity-based anorexia model. On PPD 21−22, pups were weaned and offspring
were group housed until PPD 30, where they were randomly designated to one of
two experimental groups (using a randomized complete block design to avoid
potential litter effects): (1) Control group (free food access, no RW); (2) Food-
restricted group (FR group): Free food the ﬁrst week, FR the second week, no RW;
(3) RW group (free food access in the ﬁrst week, FR in the second week, free RW).
On PND 30, which is considered the onset of adolescence in mice as determined by
the time of the ﬁrst estrous70, ICR mice in the ABA groups were placed in an RW
system in order to record running pattern (diameter 115 mm, TSE-Systems, Bad
Homburg, Germany). The protocol lasted for 11 days during which food intake
and BW were measured daily. The ﬁrst week was deﬁned as a “training period”,
during which food and water were given ad libitum. On the ﬁrst day of the second
week food access was limited to 4 h, and on the following days the food access was
limited to 3 h. Animals were deﬁned as anorexic in retrospect by cluster analysis
according to the following criteria, which was based on previous studies21–24 and
our preliminary ﬁndings: (1) Percentage weight loss; (2) Food intake during FR; (3)
Food intake recovery (%) during the FR period; (4) Circadian disruption (km ran
during the light phase); (5) Days until collapse (faint and become hypothermic)
and (6) Total running distance (km) when FR. Animals that developed ABA were
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removed from the RW cage once they collapsed and were subsequently given food
ad libitum and monitored until fully recovered. The predictive strength of the six
ABA parameters was determined by two-step cluster analysis and was used to
calculate the Z scores.
Production of lentiviral vectors. MiR-340 was PCR ampliﬁed from mouse
genomic DNA, using the following oligonucleotide primers, both carrying
restriction sites for AgeI :5′-TCTTCAAGAGGGAGCCTCAG-3′ and 3′-
AACAGGCATGATCTGTGGTG-5′. The puriﬁed PCR product (~175 bp) was
digested using AgeI enzyme and ligated to pCSC-SP-PW-IRES-GFP plasmid. MiR-
340 sequence was conﬁrmed by DNA sequencing. High titer lentiviruses expressing
miR-340 and green ﬂuorescent protein (GFP) were produced by transient trans-
fection in HEK293T cells. Infectious particles were harvested at 48 and 72 h post-
transfection, ﬁltered through 0.45 μm-pore cellulose acetate ﬁlters (Sigma-Aldrich),
concentrated by ultracentrifugation, re-dissolved in sterile HBSS, aliquoted and
stored at −80 °C. Vector concentrations were analyzed using eGFP ﬂuorescence in
HEK293T cells infected with serial dilutions of the recombinant lentivirus71,72.
Generation of placenta-speciﬁc lentiviral system. Three-week-old female mice
were hyper-ovulated with gonadotropins (PMSG) (Sigma-Aldrich) followed 48 h
later by hCG (5 IU each) and were then mated with males. Two days after the
detection of a copulation plug, oviducts were dissected (Embryonic day (ED) 2.5)
and ﬂushed with M2 medium (M7167, Sigma-Aldrich, St. Louis, MO), using a
syringe with 30-gauge blunt hypodermic needle. Embryos at their morula stage
(ED2.5) were collected and rinsed through several drops of M2 medium. The zona
pellucida was then removed by rinsing with Tyrode’s solution (M8410, Sigma-
Aldrich, St. Louis, MO). Denuded embryos were re-washed with M2 medium and
placed in 50 μl drops of M16 medium (M7292, Sigma-Aldrich, St. Louis, MO) on a
35-mm tissue culture plate. They were then incubated for 2 nights at 37 oC and 5%
CO2 for further development. Embryos at their blastocyst stage (ED4.5) were then
incubated in 30 μl drops of M16+ 3 μl concentrated lentivirus for 6 h. Using a
stripper micropipette (Cat# MD-MXL3-SRT-CGR; Zotal Ltd, Tel Aviv, Israel),
infected blastocysts were then transferred into fresh drops of M2 medium and then
into ED2.5 pseudo-pregnant females’ uterus for further development38,39. This
technique is highly speciﬁc to the transduction of the junction, therefore making
vesicular transfer highly unlikely.
Generation of pseudopregnant females. The pseudo-pregnant females were
produced by mating with sterilized males. Vasectomies were performed on 2-
month-old males by making an incision across the lower abdomen, at the midline
of the scrotal sac, under Ketamine:Xylazine (1:1 20% in saline) anesthesia. Then, a
section of the vas deferens (0.5 cm) was bilaterally removed. Males were allowed
2 weeks to recover and were mated with females to conﬁrm sterilization before the
beginning of the protocol.
Embryo tissue collection. On GD17.5, pregnant females were anesthetized with
an overdose of Ketamine-Xylazine (1:1, 20% in saline) and through cesarean sec-
tion both the embryos and placentas were excised. Embryos were weighed and
decapitated, the brain was extracted and the hypothalamus was removed, imme-
diately frozen on dry ice and stored at −80 °C. Trunk blood was collected in
EDTA-coated tubes (MiniCollect, Greiner bio-one, Austria). Placentas were also
weighed and immediately stored at −80 °C. A portion of the embryos’ tail was
removed for later DNA extraction and sex genotyping. For analyses comparing
between groups, only one fetus per litter (per sex) was used. These were chosen
from the central uterinal location, with one male and one female as adjacent
fetuses. Males chosen had one male and one female as adjacent fetuses. When the
focus was intra-litter variability, the fetuses located at the extremes of the uterus
were excluded.
Adult tissue collection. Adult animals were killed at the age of 3 months, 4 weeks
after the end of the ABA protocol and when fully recovered. After decapitation, the
hypothalamus was dissected and immediately frozen. Trunk blood was collected,
immediately centrifuged and plasma samples were and stored at −80 °C.
Genotyping. Sex of the embryo was determined by Sry genotyping (forward 5′-
TCATGAGACTGCCAACCACAG-3′ and reverse 5′-CATGACCACCACCAC-
CACCAA-3′)73. Ampliﬁcation product was detected by 2% gel electrophoresis.
Offspring physiological measurements. Pregnant and lactating dams underwent
weekly follow-up of body weight and food intake. For pre-weaning weights, total
litter weights were averaged (males and females apart). Post-weaning, pups were
weighed individually and food intake was monitored weekly.
Plasma corticosterone measurement. Corticosterone levels were analyzed using
radioimmunoassay (MP Biomedicals, Solon, Ohio, USA).
Mouse RNA extraction and real-time PCR. For placental tissue, puriﬁcation of
total RNA containing miRNAs and DNA was done using Tri Reagent (MRC Inc.,
Cincinnati, OH) according to the manufacturer’s recommendations. gDNA was
removed using Turbo DNAse digestion in solution, followed by heat deactivation
(#AM2238, Thermo Fisher Scientiﬁc). Hypothalamic RNA was extracted using the
miRNeasy Mini Kit (#217004, Qiagen) in conjunction with on column digestion of
gDNA using Turbo DNAse (see above). RNA preparations were reverse tran-
scribed to generate cDNA using miScriptII Reverse transcription kit for miRNAs/
mRNA (QIAGEN, #218160, Hilden, Germany). Quantitative mRNA/miRNA
expression were done using a SYBR®Green PCR kit (QIAGEN, Hilden, Germany)
and miScript SYBR (#204057 QIAGEN, Germany) respectively, according to the
manufacturer’s guidelines and a StepOnePlus® Real time PCR system (Applied
Biosystems, Waltham, MA), using speciﬁc primers. U6 snRNA was used as internal
control for the miRs and Tbp was used as internal control for mRNA in placental
samples.
MicroRNA Agilent array. MiRNA array of the placenta was performed using
Agilent’s microarray (SurePrint G3 Unrestricted GE 8*60k, G4872A; Agilent
Technologies, Santa Clara, CA). The bioinformatic analysis was performed using
the Limma (Liniar Models for MicroArray Data) package which is part of the
Bioconductor software (http://bioconductor.org). We corrected the background
with the Normexp method, used the Loess method for the within arrays normal-
ization and the Aquantile for between arrays normalization. A linear model was
applied in order to ﬁnd the differentially expressed genes (a simple Bayesian
model). Gene ontology analysis was performed using WebGestalt 58. (http://
bioinfo.vanderbilt.edu/webgestalt/) (Supplementary Data 1).
Taqman array. Placental gene expression of potential miR-340 targets was ana-
lyzed by a Taqman fast small RNAs assay (Applied Biosystems, Waltham, MA)
(Supplementary Table 1).
Mouse and human RT-PCR primers. See Supplementary Tables 4 and 5.
5-aza functionality assay of methylation. N42 immortalized hypothalamic cells
were plated into 35 mm plates and treated for four days with different con-
centrations (0, 0.5, 2, 10 µM) of 5-Aza-2′-Deoxycytidine (Sigma-Aldrich, St. Louis,
MO). Every day in the evening, medium was replaced with fresh growth medium
containing fresh 5-Aza. Cells were then lysed and RNA was extracted using the
miRNeasy mini kit (QIAGEN, Hilden, Germany). RNA was reverse transcribed to
cDNA using miScript Reverse transcription kit (QIAGEN, Hilden, Germany).
Global DNA methylation. Global methylation of the placenta was done using the
MethylFlash Methylated DNA Quantiﬁcation ELISA kit (Epigentek Group Inc.,
Farmingdale, NY) according to the manufacturer’s instructions.
DNA methylation of Rnf130 promoter and miR-340 sequences. Methylation
analysis by pyrosequencing of bisulﬁte-treated genomic DNA was performed by
Varionostic GmbH (http://www.varionostic.de/). Genomic DNA was bisulﬁte
converted using the EZ DNA Methylation Gold Kit (Zymo Research, Irvine, CA).
Amplicons were generated from bisulﬁte DNA covering 134 CGs in the CpG island
located in the promoter region of the Rnf130 gene and the sequence coding for
miR-340 on intron 2 (Fig. 2 and Supplementary Fig. 3). Sequencing was performed
on the Q24 System with PyroMark Q24 analysis software in CpG (QIAGEN,
Hilden, Germany). Data were analyzed using SPSS Statistics, Version 17 (SPSS Inc.,
Chicago, IL) as indicated.
Western blot. Placental protein was puriﬁed in RIPA buffer, centrifuged for 10
min at 4 oC, separated in a 10% polyacrylamide gel by electrophoresis and trans-
ferred onto nitrocellulose membranes. The transfer was performed at 100 v, 350
mAmp for 1 h. After washes with PBST (PBS+ 20% Tween20), membrane was
blocked with 10% skimmed milk in PBST for 1 h. The primary antibodies anti-
H3F3B (1:10,000, #GTX115549 GeneTex, Irvine, CA), anti-NR3C1 (GR) (1:200,
(M-20) sc-1004; Santa Cruz Biotechnology), anti-CRY2 (abcam 1:500 ab38872),
anti HDAC9 (1:500, B-1, sc-398003, Santa Cruz Biotechnology) and anti-Actin
(1:1000, sc-1616; Santa Cruz Biotechnology) were added to PBST and placed on
constant shaking at 4 oC overnight. After several washes with PBST, the secondary
antibodies (Cell Signaling Technology, Beverly, MA) were added for 1 h incubation
at RT. Finally, the membranes were visualized using ECL (Thermo Fisher Scientiﬁc,
Waltham, MA) and ﬁlm (Fujiﬁlm, Tokyo, Japan). For tests and membranes, see
Supplementary Fig. 8.
Gross placental structure analysis. The thickness of the placental section
occupied by the junctional zone (Jz) was determined on an M205C stereo
microscope (Leica, Wetzlar, Germany) and the Leica Application Suite X software
(LAS X) following eosin−hematoxylin staining by averaging three measurements
in the central area (N= 4).
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Libraries and RNAseq. Libraries were prepared with the Illumina TruSeq Stran-
ded Total RNA Library Preparation kit with Ribo Zero Gold (Illumina, #RS-122-
2301) according to the instructions, using 1000 ng total mouse placenta RNA as
starting material. Libraries were quantiﬁed on a Qubit ﬂuorometer and by qPCR
with a KAPA Library Quantiﬁcation Kit for Illumina libraries (# KK4828). Size
distribution was checked using the Agilent High Sensitivity DNA Assay (#5067-
4626) on an Agilent Bioanalyzer. Samples were denatured using 1 N NaOH, diluted
to a concentration of 3 nM with ExAMP mastermix and loaded onto a HiSeq 4000
machine (Illumina, San Diego, CA; #SY-401-4001) with 1% PhiX control (Illumina,
#FC-110-3001) spiked in. HiSeq 3000/4000 ﬂow cells and HiSeq 3000/4000 SBS
sequencing chemistry were used for paired-end sequencing with a read length of
100 bp for each direction. Sequencing was performed at the Helmholtz Center
(Munich, Germany).
RNAseq analysis. The quality of sequencing reads was veriﬁed using FastQC
0.11.5 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Adapters were
trimmed using cutadapt v.1.9.174 in paired-end mode. For quantiﬁcation of gene
expression, kallisto 0.43.175 was employed using the mouse Ensembl annotation
v79 (downloaded from http://bio.math.berkeley.edu/kallisto/transcriptomes/). The
100 bootstaps sleuth 0.28.176 was used for the analysis of differentially expressed
genes in gene aggregation mode, requiring q-values of <0.05 for both Wald and
likelihood ratio tests, with a beta value cut-off 0.25. For KEGG pathway analysis,
GAGE 2.24.077 was used with log2 transformed, ﬁltered and normalized TPM
values extracted from sleuth. An FDR of 0.1 was applied as cut-off for signiﬁcance.
BeWo cell culture. BeWo choriocarcinoma immortalized cells were plated into 35
mm plates with F12 medium with 2 mM L-glutamine, fetal bovine serum (10%) and
penicillin streptomycin solution (10,000 units/ml Penicillin GSodium Salt, 10 mg/
ml Streptomycin Sulfate) (Thermo Fisher Scientiﬁc, Waltham, MA, USA) at 37 °C
in a 5% CO2 humidiﬁed incubator. BeWo cells were treated for 48 h with lentiviral
vectors to overexpress or knockdown miR-340. Cells were then lysed and RNA was
extracted using the miRNeasy mini kit (QIAGEN, Hilden, Germany) or were lysed
using RIPA buffer for protein extraction.
Body composition. Body composition was assessed using Echo-MRI-100™ (Echo
Medical Systems, Houston, TX, USA).
Metabolic assessment. Indirect calorimetry, food and water intake were mea-
sured using the LabMaster system (TSE-Systems, Bad Homburg, Germany). The
LabMaster instrument consists of a combination of sensitive feeding and drinking
sensors for automated online measurement. The calorimetry system is an open-
circuit system that determines O2 consumption, CO2 production, and respiratory
exchange ratio. Data were collected for ﬁve consecutive days after 24 h of adap-
tation for the apparatus.
Maternal behavior. On days 6/7 and 17/18 postpartum, patterns of undisturbed
nocturnal maternal behavior were observed during 160 min sessions. Each mother
was observed every 15 min, for 1−3 s. This allowed the identiﬁcation of the
ongoing maternal behavior at the observation time. Various maternal and non-
maternal behaviors were recorded in every observation. The score was “1” if the
behavior occurred and “0” if it did not occur. Maternal behavior measures were
based on existing literature78 and included both self-(grooming, eating) and pup-
directed behaviors (nursing, licking/grooming) and activity measures.
Human placental tissue collection. Placental tissues were collected after obtaining
informed consent from pregnant women at the Division of Gynecology and
Obstetrics of the Lindenhofgruppe, Bern, Switzerland. The studies were approved
by the cantonal ethic commission of the canton of Bern (KEK), # 2016-00250.
Term placentas (38−40 weeks) were collected from uncomplicated pregnancies
after elective cesarean section without prior labor symptoms upon patients’ request
or due to breech presentation (n= 35) (Supplementary Table 2). Placental tissues
were collected from the villous tree within 1 h of delivery. To minimize blood
contamination, each piece of tissue was intensively washed in Dulbecco’s
phosphate-buffered saline. Tissue samples were then immediately snap-frozen in
liquid nitrogen and stored at −80 °C until RNA isolation. As placenta is a het-
erogeneous tissue, and physiological differences in gene expression may occur
depending on the sampling site, we standardized the sampling protocol and rou-
tinely collected tissue samples from three different locations within the placenta:
central (C), paracentral/medial (M) and peripheral/lateral (L) parts. Total RNA was
isolated similarly to the mouse samples, using cold Trizol reagent (Invitrogen Life
Technologies, Carlsbad, CA) and approximately 50 mg of frozen placental speci-
mens on wet ice79.
Statistical approach. Data were expressed as mean ± standard error of the mean
(SEM). For the Z scores data were presented in min. to max. Statistical analyses
were performed using Statistical Package for the Social Sciences (SPSS) software,
Version 20.0 (SPSS Inc., Chicago, IL) and GraphPad Prism 6 (GraphPad Software,
Inc., La Jolla, CA). Tests included repeated measures ANOVA, ttests or one-way
ANOVA when relevant. Differences between the groups were assessed using
Tukey’s multiple comparisons post hocs. When appropriate, non-parametric tests
such as Mann–Whitney and Kruskal−Wallis were used. Linear regression and r
values were determined in GraphPad Prism 6 (GraphPad Software, Inc., La Jolla,
CA).
Data availability. The Agilent miR microarray data have been deposited with
GEO-NCBI under the accession number GSE110597 and the Illumina RNA-seq
data have been deposited in the Sequence Read Archive (SRA), using the NCBI
portal, under the BioProject accession number PRJNA434509 and SRA accession
number SRP133035.
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